银屑病与银屑病关节炎患者的原因特异性死亡率
这项回顾性队列研究利用丹麦国家患者登记库,比较了医院诊断的银屑病或银屑病关节炎(PsA)患者与匹配对照者的死亡风险和死因。银屑病患者死亡率显著高于对照(HR 1.74,P<0.001),PsA患者则无显著差异(HR 1.06,P=0.19)。银屑病患者在消化系统疾病、内分泌营养代谢疾病及某些感染和寄生虫病方面的死亡风险最高。
要点
- 银屑病患者死亡率显著高于匹配对照(HR 1.74,P<0.001)。
- PsA患者死亡率与对照无显著差异(HR 1.06,P=0.19)。
- 银屑病患者死亡风险最高的死因为消化系统疾病(HR 3.61)。
核心结论
- 重度银屑病患者与匹配对照相比死亡风险增加,且由多种原因导致。
- 支持PsA患者死亡风险增加证据的说服力较弱。
研究设计与样本
- 回顾性队列研究,使用丹麦国家患者登记库识别医院诊断的PsA或银屑病患者,并从一般人群识别匹配对照者。
- 主要结局指标为银屑病或PsA患者的死亡风险和原因特异性死亡率。
主要发现
- 银屑病患者每1000患者年死亡率为22.3(95%CI 19.7-24.9),对照为13.9(95%CI 11.8-16.0)。
- PsA患者每1000患者年死亡率为10.8(95%CI 8.9-12.8),对照为11.6(95%CI 9.6-13.6)。
- 银屑病患者生存率显著低于对照(HR 1.74,P<0.001),PsA患者与对照无显著差异(HR 1.06,P=0.19)。
- 银屑病患者与对照相比,消化系统疾病(HR 3.61)、内分泌营养代谢疾病(HR 3.02)及某些感染和寄生虫病(HR 2.71)死亡风险最高。
- PsA患者仅在某些感染和寄生虫病(HR 2.80)及呼吸系统疾病(HR 1.46)方面观察到死亡率增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are limited data regarding causes of mortality in patients with psoriasis or psoriatic arthritis (PsA). OBJECTIVES: This retrospective cohort study evaluated the risk and leading causes of mortality in patients with psoriasis or PsA. METHODS: Individuals with a hospital-based diagnosis of PsA or psoriasis were identified using the Danish National Patient Registry. Matched control individuals were identified from the general population. The main outcome measures were risk of death and cause-specific mortality in patients with psoriasis or PsA. RESULTS: Death rates per 1000 patient-years (with 95% confidence intervals) vs. controls were 22·3 (19·7-24·9) vs. 13·9 (11·8-16·0) for patients with psoriasis and 10·8 (8·9-12·8) vs. 11·6 (9·6-13·6) for patients with PsA. Survival, according to stratified hazard ratios (HRs), was significantly lower in patients with psoriasis than in controls (HR 1·74, P < 0·001), but not in patients with PsA (HR 1·06, P = 0·19). Significantly increased risk of death was observed in patients with psoriasis vs. controls due to a number of causes; the highest risks were observed for diseases of the digestive system; endocrine, nutritional and metabolic diseases; and certain infectious and parasitic diseases (HRs 3·61, 3·02 and 2·71, respectively). In patients with PsA, increased mortality was observed only for certain infectious and parasitic diseases (HR 2·80) and diseases of the respiratory system (HR 1·46). Patients with psoriasis died at a younger age than controls (mean age 71·0 vs. 74·5 years, P < 0·001). CONCLUSIONS: Patients with severe psoriasis have increased mortality risk compared with matched controls, due to a number of causes. Evidence to support an increased risk for patients with PsA was less convincing.
引用
- Skov L, Thomsen SF, Kristensen LE, et al. Cause-specific mortality in patients with psoriasis and psoriatic arthritis. Br J Dermatol. 2018. PMID: 29947129. doi:10.1111/bjd.16919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。